Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Carrillo

Showing results (91-100 of 242) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|October 21, 2020
Active immunotherapy and alternative therapeutic modalities for Alzheimer's diseaseStacie Weninger, Bjorn Sperling, Robert Alexander, et al.
JAMA Neurology|November 30, 2020
Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive ImpairmentLeonardo Iaccarino, Renaud La Joie, Orit H Lesman-Segev, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
Advancing combination therapy for Alzheimer's diseaseStephen P Salloway, Jeff Sevingy, Kumar Budur, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumYuta Katsumi, Ryan Eckbo, Michael Brickhouse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 31, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?Peter J Snyder, Kristin Kahle-Wrobleski, Stephen Brannan, et al.
Nature Reviews. Neurology|September 22, 2021
The case for low-level BACE1 inhibition for the prevention of Alzheimer diseaseEric McDade, Iryna Voytyuk, Paul Aisen, et al.
Nature Reviews. Neurology|September 30, 2015
CAP--advancing the evaluation of preclinical Alzheimer disease treatmentsEric M Reiman, Jessica B Langbaum, Pierre N Tariot, et al.
JAMA|April 3, 2019
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or DementiaGil D Rabinovici, Constantine Gatsonis, Charles Apgar, et al.
Pageof 25

Showing results (91-100 of 242) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia (New York, N. Y.)|October 21, 2020
Active immunotherapy and alternative therapeutic modalities for Alzheimer's diseaseStacie Weninger, Bjorn Sperling, Robert Alexander, et al.
JAMA Neurology|November 30, 2020
Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive ImpairmentLeonardo Iaccarino, Renaud La Joie, Orit H Lesman-Segev, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
Advancing combination therapy for Alzheimer's diseaseStephen P Salloway, Jeff Sevingy, Kumar Budur, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumYuta Katsumi, Ryan Eckbo, Michael Brickhouse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 31, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?Peter J Snyder, Kristin Kahle-Wrobleski, Stephen Brannan, et al.
Nature Reviews. Neurology|September 22, 2021
The case for low-level BACE1 inhibition for the prevention of Alzheimer diseaseEric McDade, Iryna Voytyuk, Paul Aisen, et al.
Nature Reviews. Neurology|September 30, 2015
CAP--advancing the evaluation of preclinical Alzheimer disease treatmentsEric M Reiman, Jessica B Langbaum, Pierre N Tariot, et al.
JAMA|April 3, 2019
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or DementiaGil D Rabinovici, Constantine Gatsonis, Charles Apgar, et al.
Pageof 25